OGI Bio has been featured as part of the Biotechnology and Biological Sciences Research Council (BBSRC)’s Synthetic Biology for Growth Program. BBSRC’s funding and support have been instrumental in helping OGI Bio develop its innovative microbial culturing automation systems, which are transforming the way scientific research is conducted in laboratories worldwide.
From Concept to Innovation
Founded in 2020, OGI Bio set out to revolutionize microbial culturing, a critical process in microbiology and biotechnology. Traditional culturing methods can be time-consuming and resource-intensive, limiting researchers’ ability to scale their work effectively. OGI Bio’s goal was to develop an automated system that could drastically increase productivity, reduce costs, and streamline microbial research.
With the support of BBSRC, OGI Bio was able to accelerate the development of its automated culturing systems, which significantly improve the efficiency and accuracy of microbial cultivation. By automating routine tasks, the system allows researchers to focus on more complex scientific questions, ultimately advancing discovery in fields like microbiology, synthetic biology, and biotechnology.
Key Achievements and Impact
Thanks to BBSRC’s backing, OGI Bio made remarkable progress in 2024. The company achieved key milestones, including:
- Launching the Mk2 System, a state-of-the-art microbial culturing system that delivers enhanced performance, scalability, and ease of use.
- Receiving industry recognition, including being named KPMG Tech Innovator of Scotland and advancing to the UK finals.
- Securing seed investment and Innovate UK funding, which enabled further product development and global expansion.
These achievements have positioned OGI Bio as a leader in microbial automation and a key player in the biotechnology sector.
Supporting Scientific Progress
OGI Bio’s success highlights the critical role of government funding and support from organizations like BBSRC in fostering innovation. The collaboration has allowed the company to develop technologies that not only improve lab efficiency but also enable researchers to conduct more sustainable, cost-effective experiments. By making microbial culturing more accessible, OGI Bio is helping to drive forward scientific progress across a range of disciplines.
“We are incredibly grateful for the support from BBSRC,” said Dr. Alex McVey, CEO of OGI Bio. “Their funding and resources have been pivotal in helping us turn our vision into reality. This partnership has allowed us to create solutions that are truly transforming the way researchers work.”